Polysaccharide conjugate vaccine against pneumococcal pneumonia in adults

The New England Journal of Medicine
Marc J M BontenDiederick E Grobbee

Abstract

Pneumococcal polysaccharide conjugate vaccines prevent pneumococcal disease in infants, but their efficacy against pneumococcal community-acquired pneumonia in adults 65 years of age or older is unknown. In a randomized, double-blind, placebo-controlled trial involving 84,496 adults 65 years of age or older, we evaluated the efficacy of 13-valent polysaccharide conjugate vaccine (PCV13) in preventing first episodes of vaccine-type strains of pneumococcal community-acquired pneumonia, nonbacteremic and noninvasive pneumococcal community-acquired pneumonia, and invasive pneumococcal disease. Standard laboratory methods and a serotype-specific urinary antigen detection assay were used to identify community-acquired pneumonia and invasive pneumococcal disease. In the per-protocol analysis of first episodes of infections due to vaccine-type strains, community-acquired pneumonia occurred in 49 persons in the PCV13 group and 90 persons in the placebo group (vaccine efficacy, 45.6%; 95.2% confidence interval [CI], 21.8 to 62.5), nonbacteremic and noninvasive community-acquired pneumonia occurred in 33 persons in the PCV13 group and 60 persons in the placebo group (vaccine efficacy, 45.0%; 95.2% CI, 14.2 to 65.3), and invasive pneumococ...Continue Reading

References

Dec 16, 1992·JAMA : the Journal of the American Medical Association·R S Baltimore
Jan 1, 1986·Pediatric Infectious Disease·M KoskelaP H Mäkelä
Apr 27, 2000·The Pediatric Infectious Disease Journal·H R Shinefield, S Black
Feb 15, 2001·The New England Journal of Medicine·J EskolaUNKNOWN Finnish Otitis Media Study Group
May 2, 2003·The New England Journal of Medicine·Lisa A JacksonUNKNOWN Vaccine Safety Datalink
Oct 3, 2003·The New England Journal of Medicine·Keith P KlugmanUNKNOWN Vaccine Trialists Group
Jan 7, 2009·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Anke HussMatthias Egger
Mar 5, 2010·The New England Journal of Medicine·Neil FrenchCharles F Gilks
Oct 25, 2012·Emerging Infectious Diseases·Anna M M van DeursenUNKNOWN Invasive Pneumococcal Disease Sentinel Surveillance Laboratory Group
Dec 18, 2012·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·M H RozenbaumE Hak
Feb 12, 2013·The European Respiratory Journal·Susanne M HuijtsMarc J M Bonten
May 2, 2014·Transactions of the Royal Society of Tropical Medicine and Hygiene·Leon PetoHeiman F L Wertheim

❮ Previous
Next ❯

Citations

Feb 22, 2016·Medicina clínica·Rafael Zalacain
Feb 13, 2016·The Journal of Infection·Imma GrauRoman Pallares
Feb 26, 2016·Archivos de bronconeumología·Enrique MascarósUNKNOWN en nombre de Neumoexpertos en Prevención
Jan 24, 2016·Journal of the American Pharmacists Association : JAPhA·Salisa C WestrickThanasak Lertpichitkul
Jan 12, 2016·Vaccine·Maartje KristensenHester E de Melker
Dec 24, 2015·Journal of the American Geriatrics Society·Tadahiro GotoKohei Hasegawa
Feb 2, 2016·Medicina clínica·Antoni Payeras, María Arrizabalaga
Sep 27, 2015·Translational Research : the Journal of Laboratory and Clinical Medicine·John E McKinnon, Kathleen Maksimowicz-McKinnon
Nov 26, 2015·Vaccine·Altynay ShigayevaUNKNOWN Toronto Invasive Bacterial Diseases Network
Feb 24, 2016·Human Vaccines & Immunotherapeutics·Peter R Paradiso
Feb 24, 2016·Human Vaccines & Immunotherapeutics·Ruth Gil-PrietoÁngel Gil-De-Miguel
Feb 26, 2016·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·Alexander Kuhlmann, J-Matthias Graf von der Schulenburg
Sep 1, 2015·British Journal of Haematology·Ernest KucharMonika Karlikowska
Dec 26, 2015·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Christian TheilackerUNKNOWN Splenectomy, Pneumococcus, and Fulminant Infection SPLEEN OFF Study Group
Jan 14, 2016·Immunity & Ageing : I & a·Susanna EspositoNicola Principi
Dec 15, 2015·Expert Review of Vaccines·Raul E IsturizPeter Paradiso
Sep 12, 2015·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Altynay ShigayevaUNKNOWN Toronto Invasive Bacterial Diseases Network
Sep 12, 2015·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Manel Luján, Miguel Gallego
Nov 26, 2015·Vaccine·Anna M M van DeursenUNKNOWN Carriage Pilot Study Group
Oct 18, 2015·Enfermedades infecciosas y microbiología clínica·Magda Campins Martí
Nov 5, 2015·Human Vaccines & Immunotherapeutics·Kristin Moffitt, Richard Malley
Sep 26, 2015·Human Vaccines & Immunotherapeutics·Ho NamkoongNaoki Hasegawa
Nov 29, 2015·Vaccine·Carolyn B BridgesAmy V Groom
Nov 27, 2015·The Lancet. Respiratory Medicine·Pekka Nuorti, Arthur Reingold
Jul 19, 2015·Revista clínica española·M Falguera, M F Ramírez
Feb 20, 2016·Expert Review of Respiratory Medicine·Adamantia Liapikou, Antoni Torres
Oct 13, 2015·Journal of the American Geriatrics Society·Sylvia Becker-DrepsPhilip Sloane
Aug 13, 2015·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Cornelis H van WerkhovenMarc J M Bonten
Nov 26, 2015·Human Vaccines & Immunotherapeutics·Daniel M Musher, Maria B Rodriguez-Barradas
Jun 26, 2015·Human Vaccines & Immunotherapeutics·Ella J Ariza-Heredia, Roy F Chemaly
Sep 14, 2015·La Presse médicale·Laila Baratali, Pierre Olivier Lang
Nov 28, 2015·Infectious Disease Clinics of North America·Inci YildirimStephen I Pelton
Jul 23, 2016·Canadian Respiratory Journal : Journal of the Canadian Thoracic Society·Shelly A McNeilCraig Laferriere

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.